Prot #PTC596-ONC-008-LMS: A Phase 2/3 Study to Evaluate the Efficacy and Safety of Unesbulin in Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma

Project: Research project

Project Details

StatusActive
Effective start/end date10/10/2210/10/25

Funding

  • Medpace, Inc. ((OE) Prot #PTC596-ONC-008-LMS // (OE) Prot #PTC596-ONC-008-LMS)
  • PTC Therapeutics, Inc. ((OE) Prot #PTC596-ONC-008-LMS // (OE) Prot #PTC596-ONC-008-LMS)